ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0103 • ACR Convergence 2025

    Common and Rare Variant Contributions to Familial Aggregation in Spondyloarthritis

    Félicie Costantino1, roula Said-Nahal2, Hendrick Mambu Mambueni3, Anne Boland4, Jean-François Deleuze4, Matthew Brown5, Henri-Jean Garchon3 and Maxime Breban6, 1Department of Rheumatology, Ambroise Paré Hospital, AP-HP, Paris, France and Infection & Inflammation, UMR 1173, Inserm, UVSQ/Université Paris Saclay, Montigny-Le-Bretonneux, France, 2Department of Rheumatology, Ambroise Paré Hospital, AP-HP, Paris, France and Infection & Inflammation, UMR 1173, Inserm, UVSQ/Université Paris Saclay, Boulogne-Billancourt, France, 3Infection & Inflammation, UMR 1173, Inserm, UVSQ/Université Paris Saclay, Montigny le Bretonneux, France, 4Centre National de Recherche en Génomique Humaine (CNRGH), Centre National de Recherche en Génomique Humaine (CNRGH), Université Paris-Saclay, CEA, Evry, France, 5Department of Medical and Molecular Genetics, King's College London, London, United Kingdom, 6CHU Ambroise-Paré, Boulogne-Billancourt, France

    Background/Purpose: Spondyloarthritis (SpA) exhibits strong familial aggregation, with close relatives of patients having a significantly higher risk of developing the disease. This pattern might be…
  • Abstract Number: 0032 • ACR Convergence 2025

    Protein Language Model-Guided Homology Identifies Microbial Enzymes Linked to Fibrosis-Prone IgG4-RD and Crohn’s Disease

    Kumar Thurimella1, Ahmed Mohamed2, Chenhao Li3, Tommi Vatanen4, Daniel Graham3, Roisin Owens5, Sabina Leanti La Rosa6, Damian Plichta3, Sergio Bacallado5 and Ramnik Xavier7, 1University of Colorado School of Medicine, Aurora, CO, 2Broad Institute, Boston, 3Broad Institute, Cambridge, MA, 4University of Helsinki, Helsinki, Finland, 5University of Cambridge, Cambridge, United Kingdom, 6NMBU, As, Norway, 7Harvard Medical School, Boston, MA

    Background/Purpose: Uncharacterized microbial enzymes in metagenomics are difficult to annotate, especially in fibrosis-prone conditions like IgG4-related disease (IgG4-RD) and Crohn’s disease (CD), where microbial carbohydrate…
  • Abstract Number: 0037 • ACR Convergence 2025

    A Proteomic Signature Containing TNF Receptor Superfamily Member 10A (TNFRSF10A) and Growth/Differentiation Factor 15 (GDF-15) Improves Prediction of All-Cause Mortality Among Individuals with Gout, Beyond Atherosclerotic Cardiovascular and Other Clinical Risk Factors

    Natalie McCormick1, Sharan Rai2, Chio Yokose3, Tony Merriman4, Robert Terkeltaub5 and Hyon K. Choi6, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital/Harvard Medical School, Boston, MA, 3Massachusetts General Hospital, Waltham, MA, 4University of Alabama at Birmingham, Homewood, AL, 5Retired, San Diego, CA, 6MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA

    Background/Purpose: Gout affects >12 million US adults and is associated with premature all-cause and cardiovascular (CV) mortality which has failed to improve over recent decades,…
  • Abstract Number: 0044 • ACR Convergence 2025

    DNA Methylation Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis Highlight Divergent Immune Pathways

    Rufei Lu1, Tayte Stephens2, Carla Guthridge1, Miles Smith1, Joseph Kheir1, Cristina Arriens1, Joan Merrill3, Marci Beel4, Susan Macwana1, Wade DeJager5, Nicholas Domingez1, Teresa Aberle1, Joel Guthridge1 and Judith James1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Oklahoma Health Science Center, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City 73104, OK, 4Oklahoma Medical Research Foun, Oklahoma City, OK, 5Oklahoma Medical Research Foundation, Oklahoma City

    Background/Purpose: Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are autoimmune diseases with distinct clinical and immunopathological features. Epigenetic modifications, particularly DNA methylation, contribute to…
  • Abstract Number: 0002 • ACR Convergence 2025

    KITE-363: An Autologous Anti-CD19/CD20 CAR-T Product for the Treatment of Autoimmune Rheumatic Diseases

    Brian Kim, Christine Lowe, Francisco Flores, Jeremy Margaitis, Alessandro Calo, Stacey Valny, Anna Konecny, Eva Jaghatspanyan, Sean Yoder, Kenneth Ertel, Simone Filosto, Jodi Murakami and David Barrett, Kite, a Gilead Company, Santa Monica, CA

    Background/Purpose: B-cell dysregulation is a key factor in the development and progression of autoimmune diseases, and B-cell inhibition has been a cornerstone of treatment for…
  • Abstract Number: 0085 • ACR Convergence 2025

    Single Cell RNA-seq Revealed Immune/epithelial Cell Abnormalities Underlying the Pathogenesis of Rheumatoid Arthritis-related Interstitial Lung Disease

    Kensuke Suga1, Amara Seng2, Changfu Yao3, Tanyalak Parimon3, Youn Jung Choi2, Justyna Fert-Bober4, Barry Stripp3, Jon Giles5, Peter Chen3 and Nunzio Bottini6, 1Kao Autoimmunity Institute, Cedars-Sinai Medical Center, Beverly Hills, CA, 2Kao Autoimmunity Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 3Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 4Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 5Cedars Sinai Medical Center, Los Angeles, CA, 6Cedars Sinai Medical Center, Beverly Hills, CA

    Background/Purpose: Interstitial lung disease (ILD) is one of the extra-articular manifestations of rheumatoid arthritis (RA) characterized by inflammation and/or fibrosis. Clinically relevant RA-ILD occurs in…
  • Abstract Number: 0347 • ACR Convergence 2025

    Identifying Risk Factors for Fragility Fractures in Patients with Coeliac Disease: An Observational Study

    Kabyar Cho1, Hamzah Amin2 and marwan Bukhari3, 1University Hospitals of Morecambe Bay NHS Foundation Trust, Barrow-In-Furness, United Kingdom, 2Lancaster University, Lancaster, United Kingdom, 3University Hospitals of Morecambe bay NHS foundation trust, Lancaster, United Kingdom

    Background/Purpose: Coeliac disease (CD) is an autoimmune disease, which has been widely reported to be associated with reduced bone mineral density (BMD), leading to an…
  • Abstract Number: 0355 • ACR Convergence 2025

    Changes in scanographic bone mineral density in melanoma patients treated with immunotherapy

    Soukayna Baddi1, Suarez Dimitri1, Alexis Ruet1, Theo Van Butsel1, Damiano Cerasuolo1, Jean-Matthieu L’Orphelin1 and Anne-Christine Rat2, 1Caen University Hospital, Caen, France, 2Caen University hospital, UMR 1075 Caen normandy university, Caen, France

    Background/Purpose: The use of immune checkpoint inhibitors (ICIs) is becoming increasingly important in the management of melanoma. However, although ICIs are associated with various immune-related…
  • Abstract Number: 0354 • ACR Convergence 2025

    Greater Neighborhood Walkability is Associated with Lower Incidence of Hip Fracture in Older, Community-dwelling Women in the United States: The Cardiovascular Health Study

    Rachel Elam1, Petra Buzkova2, Howard Fink3, Joshua Barzilay4, Eric Roseen5, Jane Cauley6, John Robbins7, Laura Carbone1, Gina Lovasi8 and Kenneth Mukamal9, 1Augusta University, Augusta, GA, 2University of Washingon, Seattle, WA, 3University of Minnesota, Minneapolis, MN, 4Kaiser Permanente of Georgia, Atlanta, GA, 5Boston University, Boston, MA, 6University of Pittsburgh, Pittsburgh, PA, 7University of California Davis, Davis, CA, 8Drexel University, Philadelphia, PA, 9Beth Israel Deaconess Medical Center, Brookline, MA

    Background/Purpose: Higher physical activity is linked to reduced fracture risk in older adults, especially for hip fractures. Emerging evidence demonstrates a potential role for the…
  • Abstract Number: 0298 • ACR Convergence 2025

    Inter-rater Reliability of Hand-Held Dynamometry in Patients with Idiopathic Inflammatory Myopathy

    Niladri Bhowmick1, Shashank Suresh2, Didem Saygin3, Siamak Moghadam-Kia4, Dana Ascherman5, Chester V. Oddis5 and Rohit Aggarwal6, 1University of Pittsburgh Medical Center, Pittsburgh, 2Atrium Health, Charlotte, NC, 3Rush University Medical Center, Chicago, IL, 4University of Pittsburgh Medical Center, Pittsburgh, PA, 5University of Pittsburgh, Pittsburgh, PA, 6University of Pittsburgh, Rheumatology and Clinical Immunology, Pittsburgh, United States of America, Pittsburgh, PA

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are characterized by symmetrical proximal muscle weakness. Accurate and reliable assessment of muscle strength is important for diagnosis, monitoring, and…
  • Abstract Number: 0312 • ACR Convergence 2025

    Efficacy and Safety of Tocilizumab in Children with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis

    Kainat Jahangir1, Meer Murtaza2, Rida Ul Jannat3, Muhammad Arham4, Najam Gohar5, Faseeh Haider6, Rohma Ahmed7, FNU Raja8, Rabie Habib9, Mahnoor Umar10, Hira Saleem11, Faizan Ahmed12, Tehmasp Mirza13, Momina Siddiqui14, Muhammad Umer15, Haziq Ahmed16, Maryam Anwar17, Rehab Bint e Tahir18, Yusra Junaid19 and Ramsha Ali20, 1Dow Medical College, Karachi, Pakistan, 2Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan, 3Wake Forest University, Winston Salem North Carolina, Winston-Salem, NC, 4Sheikh Zayed Medical College, Lahore, Pakistan, 5Ameer Ud Din Medical College, Sialkot, Pakistan, 6Allama Iqbal Medical college, Lahore, Punjab, Pakistan, 7Fatima Jinnah Medical University, Lahore, Pakistan, 8Federal Medical and Dental College, Islamabad, Pakistan, 9Baylor College of Medicine, Texas, Pakistan, 10Nassau University Medical Center, New York, 11Houston Methodist Hospital, Texas, 12Corewell health, dearborn, MI, 13Shalamar Medical and Dental College, Lahore, Pakistan, 14Rawalpindi Medical Univeristy, Rawalpindi, Punjab, Pakistan, 15King Edward Medical College, Lahore, Pakistan, 16Sheikh Khalifa bin zayed Alnahyan Medical College, Lahore, Punjab, Pakistan, 17Baqai Medical University, Karachi, Pakistan, 18-, lahore, 19Dow University of health and sciences, karachi, Pakistan, 20Peoples University of Medical and Health Sciences SBA, NawabShah, Pakistan

    Background/Purpose: Juvenile idiopathic arthritis (JIA) encompasses various chronic inflammatory conditions in children that lead to joint discomfort and potential disability. Tocilizumab, an antibody targeting interleukin-6,…
  • Abstract Number: 0326 • ACR Convergence 2025

    Gender Disparities in Clinical Outcomes Among Older Adults with Knee Osteoarthritis: A Retrospective Cohort Study

    Kinga Grzybowski1, Ahmer Khan2, Samuel Bonomo3 and Arthur Lau4, 1Jefferson Einstein Montgomery Hospital, Maspeth, NY, 2Jefferson Einstein Philadelphia Hospital, Philadelphia, 3Jefferson Einstein Montgomery Hospital, East Norriton, PA, 4Jefferson Einstein Hospital, Maple Glen, PA

    Background/Purpose: Osteoarthritis (OA) is the most common type of arthritis which classically affects multiple joints, mainly the knees. About 595 million people worldwide suffer from…
  • Abstract Number: 0299 • ACR Convergence 2025

    Interpreting Myositis Autoantibody Line-Blot Immunoassays in Real-World Settings: Implications for Diagnostic Accuracy for Inflammatory Myopathies

    pei-Hsinq lai1, TING-YUAN LAN2, Chiao-Feng Cheng3, Tai-Ju Lee4, Ting-Wei Chang5, Jui-Hung Kao6, Kuan-Yen Lin7, Cheng-Hsun Lu8, Chiehyu Shen9, Ko-Jen Li8 and Song-Chou Hsieh10, 1Taipei City Hospital, Taichung, Taiwan, 2National Taiwan University Hospital Hsinchu Branch, Hsinchu City, Taiwan, 3National Taiwan University Hospital, Taipei City, Taiwan (Republic of China), 4National Taiwan University Hospital Hsinchu Branch, Hsinchu City, Taiwan (Republic of China), 5National Taiwan University Hospital Hsinchu Branch, Taichung, Taiwan, 6Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, Taipei, Taiwan (Republic of China), 7National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu City, Taiwan (Republic of China), 8National Taiwan University Hospital, Taipei, Taiwan, 9National Taiwan University Hospital, Taipei city, Taiwan, 10National Taiwan Unuversity Hospital, Taipei City, Taiwan (Republic of China)

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) present with diverse clinical features and disease courses. The myositis autoantibody line blot immunoassay (LIA) has advanced IIM diagnostics and…
  • Abstract Number: 0313 • ACR Convergence 2025

    People with Knee Osteoarthritis Infrequently Seek Medical Care for Arthritis, Even Those With Severe Disease

    Grace Lo1, Shunshun Yan2, Julieann Patarini3, Timothy McAlington4, Charles Eaton5 and Jeffrey Driban6, 1Baylor College of Medicine / MEDVAMC, Houston, TX, 2Baylor College of Medicine, Houston, 3UMass Chan Medical School, Worcester, MA, 4UMass Chan School of Medicine, Arlington, MA, 5Brown University, Providence, RI, 6University of Massachusetts Chan Medical School, Marlborough, NH

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis, a condition associated with substantial disability. Providers are often uncomfortable managing arthritis, and patients with…
  • Abstract Number: 0065 • ACR Convergence 2025

    Expression and Co-Localization of Malondialdehyde-Acetaldehyde and Citrullinated Proteins in Myocardial Tissues Precedes the Development of Cardiac Fibrosis in Collagen-Induced Arthritis

    Wenxian Zhou1, Hannah Johnson2, Michael Duryee2, Ali Namvaran3, Julian Garcia2, Carlos Hunter2, Tate Johnson2, Daniel Anderson4, Kishore Bidasee2, Geoffrey Thiele2 and Ted Mikuls2, 1University of Nebraska Medical Center, Bellevue, NE, 2University of Nebraska Medical Center, Omaha, NE, 3University of Nebraska Medical Center, Omaha, 40587964, Durham, NC

    Background/Purpose: Patients with rheumatoid arthritis (RA) experience increased morbidity and mortality due to heart failure with preserved ejection fraction (HFpEF), a condition characterized by diastolic…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 2605
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology